Kozni ambulance Fialova s.r.o. — Clinical Trial Site

14 Registered trials

3 Currently recruiting

Organisation

Kozni ambulance Fialova s.r.o.

Location

Prague, Czechia

Identifier

ORG-100045737

Address

Evropska 1724/59, Dejvice, 160 00, Czechia

Departments

42004: Dermatologie / Dermatology
Dermatology
Dermatovenerology
n/a
NA

Clinical trials at this site (14)

Search interface

Study to Evaluate the Efficacy and Safety of ATI-045 in Atopic Dermatitis Not authorised

2024-520302-19-00 Atopic dermatitis 4
A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis Recruiting

2024-519795-11-00 Atopic Dermatitis 4 2025-10-06
Long-Term Safety and Efficacy evaluation of amlitelimab in participants of previous amlitelimab moderate to severe atopic dermatitis clinica… Recruiting

2023-506548-18-00 Dermatitis atopic 10 2022-11-10
A study to learn if galvokimig is safe and works in adults with moderate to severe atopic dermatitis Recruiting

2025-522578-35-00 Atopic Dermatitis 4 2026-03-30
A Study of Two Doses of Ritlecitinib in People 12 Years of Age and Older with Alopecia Areata Ended

2024-519370-40-00 Alopecia areata 5 2025-07-16
A study to investigate improvement in pruritus of Lichen Simplex Chronicus with dupilumab injections compared with placebo in male and fema… Ended

2024-514762-39-00 Neurodermatitis 5 2025-03-03
A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended

2024-513208-32-00 Chronic Spontaneous Urticaria 5 2024-12-16
A study to evaluate the treatment response and safety of two dose regimens of subcutaneous amlitelimab compared with treatment withdrawal in… Ended

2023-508096-36-00 atopic dermatitis 5 2024-10-30
A Study to Evaluate the Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis Ended

2024-511260-84-00 Atopic Dermatitis 4 2024-09-03
Open label, long-term study evaluating safety and efficacy of subcutaneous amlitelimab in participants aged 12 years and older with moderate… Ended

2022-502188-39-00 Dermatitis atopic 4 2023-09-27
A study to investigate the efficacy and safety of subcutaneous lunsekimig (SAR443765) compared with placebo in adult participants with moder… Ended

2024-511549-20-00 Dermatitis atopic 4 2025-04-22
A Phase 2, Dose-Ranging Study of LY4100511 (DC-853) in Adult Participants with Moderate-to-Severe Plaque Psoriasis Ended

2024-512207-39-00 Plaque Psoriasis 4 2025-01-30
A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in participants aged 12 years and … Ended

2023-506557-38-00 Dermatitis atopic 5 2024-05-16
Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE) Ended

2022-501523-24-00 Cutaneous Lupus Erythematosus (CLE) 4 2023-10-12